Fibromyalgia is a multi-symptomatic disorder characterized by generalized pain. The pathophysiology of fibromyalgia is supposedly an interplay between central nervous system hyper-responsiveness, autonomic dysfunction, and peripheral pain. In this cross-sectional study, the objective was to assess central sensitization and autonomic activity in patients with fibromyalgia compared with control. Fifty adults diagnosed with fibromyalgia by the modified American College of Rheumatology 2010 criteria and an equal number of age- and sex-matched controls participated in the study in an urban tertiary care hospital. Central sensitization was assessed by history and by evidence of increased prefrontal cortical activity as measured by cortical oxygenation using functional near-infrared spectroscopy. Autonomic activity was assessed by heart rate variability, electrodermal activity, and deep breathing test in three physiological states: rest, sympathetic stress (cold pressor test), and deep breathing. Mann–Whitney U-test, paired t-test, Wilcoxon test, and Friedman test with Bonferroni a priori were used to analyze the data. Cortical activity was significantly higher in the fibromyalgia group than control. There was no significant difference in autonomic activity between the fibromyalgia and control groups. In the fibromyalgia group, variable degrees of sympathetic hyperactivity and normal parasympathetic activity were observed. Central sensitization may be playing a primary role in the pathophysiology of generalized pain in fibromyalgia.
Objective: To observe changes in cystometric parameters in individuals with spinal cord injury (SCI) with neurogenic bladder practicing clean intermittent self-catheterization (CIC) and incidence of urinary tract infection (UTI) in such patients. Design: Prospective, observational study. Setting: Tertiary Urban Rehabilitation Hospital. Participants: Persons with neurogenic bladder caused by traumatic SCI and practicing CIC. Interventions: Clinical evaluation, complete urine analysis, urine culture and sensitivity, ultrasonography of the abdomen and urodynamic study were evaluated at baseline and at follow-up (6 months to 1 year). Outcome Measures: Detrusor pattern, cystometric capacity, detrusor compliance, detrusor leak point pressure, residual urine, incidence of UTI. Results: Thirty-one participants were included in the study. The baseline cystometric study showed that 15 had overactive detrusor and 16 had detrusor areflexia. The mean cystometric capacity decreased significantly between baseline and follow-up in both the groups but remained within the normal threshold limit, decline being more marked in the overactive detrusor group, who also had more marked decrease in compliance. Mean detrusor leak point pressure was below 40 cm H2O in all participants in both groups at baseline and follow-up. Mean residual urine improved at follow-up in both groups. Incidence of UTI was 2.29 episodes per patient per year, and more frequent in the overactive detrusor group. Escherichia coli was the causative agent in 45%. Conclusion: The cystometric capacity and compliance decreased significantly though patients were doing regular CIC and managed on antimuscarinics for detrusor overactivity (DO). UTI is more common in individuals with SCI with DO and E. coli is the most common cause of UTI.
Sonomyography (SMG) is a non-invasive technique that uses ultrasound imaging to detect the dynamic activity of muscles. Wearable SMG systems have recently gained popularity due to their potential as human-computer interfaces for their superior performance compared to conventional methods. This paper demonstrates real-time positional proportional control of multiple gestures using a multiplexed 8-channel wearable SMG system. The amplitude-mode ultrasound signals from the SMG system were utilized to detect muscle activity from the forearm of 8 healthy individuals. The derived SMG signals were used to control the on-screen position of the cursor. A target achievement task was performed to analyze the performance of our SMG-based human-machine interface. Our wearable SMG system provided accurate, stable, and intuitive control in real-time by achieving an average success rate greater than 80% with all gestures. Furthermore, the wearable SMG system’s abilities to detect volitional movement and decode movement kinematic information from SMG trajectories using standard performance metrics were evaluated. Our results provide insights to validate SMG as an intuitive human-machine interface.
3 July 2024 in The Journal of Spinal Cord Medicine
This study is a randomized, investigator-blinded, controlled trial with a non-inferiority design. To investigate the effectiveness of neuromodulation by transcutaneous electrical stimulation of the somatic afferent nerves of the foot in neurogenic detrusor overactivity (NDO) in persons with spinal cord injury (SCI) and compare its effectiveness with oral oxybutynin. The study was conducted in a rehabilitation in-patient ward of a tertiary care hospital. Twenty-nine persons with SCI with NDO, either sex, aged 18 years and above were randomized into two groups, one group receiving oral oxybutynin (5 mg thrice a day for two weeks) and the other transcutaneous electrical stimulation (5 Hz, 200 µs pulse, biphasic, amplitude up to 60 mA, 30 min/day for two weeks). Bladder capacity was evaluated by clinical bladder evaluation (i.e. bladder capacity measured by adding leak volume, voiding volume if any, and post-void residue using a catheter) and cystometric bladder capacity by one-channel cystometry. Maximum cystometric pressure was evaluated by one-channel water cystometry. Data were analyzed with Fisher's Exact, t-test, and Wilcoxon rank sum tests. Bladder capacity improved significantly in the oxybutynin and neuromodulation groups as measured by one-channel water cystometry (136 ml vs. 120.57 ml) and clinical evaluation (138.93 ml vs. 112 ml). The increase in the neuromodulation group achieved the pre-decided non-inferiority margin of 30 ml over the oxybutynin group when measured by one-channel water cystometry but not by clinical evaluation. Maximum cystometric pressure did not significantly improve in either group when compared with the baseline. Transcutaneous neuromodulation and oxybutynin effectively increased bladder capacity in persons with SCI with NDO. Neuromodulation by once-a-day transcutaneous electrical stimulation was non-inferior to thrice-a-day oxybutynin when evaluated by one-channel water cystometry.Trial registration: Clinical Trials Registry India identifier: CTRI/2018/05/013735.
1 May 2023 in Indian Journal of Physical Medicine and Rehabilitation
Neurogenic bladder in persons with spinal cord injury (SCI) is a critical issue as it can lead to significant morbidity and mortality. Complications such as urinary tract infection, bladder/renal stones, social embarrassment from incontinence and renal damage are some complications related to neurogenic bladder if managed inadequately. In India, the average annual incidence of SCI is 15,000 with a prevalence of 0.15 million. Most of these are illiterate, belonging to a low-income group with poor living conditions. Incontinence, social withdrawal and infection can pose a major impediment to vocational rehabilitation, community integration and living an independent life. The goals of the management of neurogenic bladder are to prevent incontinence, allow adequate storage till emptying of the bladder at an appropriate time and prevent infection and upper tract damage. In recent times, various pharmacological, non-pharmacological and surgical options have come up. While some are feasible in the Indian scenario, some are still not. Furthermore, there is a dearth of data related to SCI. The purpose of this review is to present the recent literature on the management of neurogenic bladder with a special focus on patients with traumatic SCI.